Skip to main content
Caplight Logo









Anthology

Anthology

Private
Cambridge, MassachusettsHealthcare & Life Scienceshttps://anthology.bio/

Last Round

Seed

Mar 20, 2026

Total Funding Raised

$12.19M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Anthology is a biotechnology company that develops a genome evolution technology designed to scale biomanufacturing.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Medical AI

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

programmable medicinessynthetic biologydrug discoverybiomanufacturinggenome engineeringcomputational biologybiofoundrygenome language modelAI-driven drug discoveryprotein engineeringgenotype-phenotype mappingbiotech platformaccelerated evolutiondata as a serviceDaaS

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Anthology Comparables

Compare Anthology with similar companies based on industry and business-model similarity.

Anthology comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Octant
80%
Recursion Pharmaceuticals
76%
Hexagon Bio
73%

Anthology Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedMar 20, 2026
GrantDec 20, 2024
SeedDec 14, 2023

Key People

Founding team and executive leadership

Tzu-Chieh Tang

Co-Founder and CTO

Founding Team

Anthology Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 10, 2026

    Open roles increased to 13, 65% of headcount.

  • Jul 20, 2026

    Open roles increased to 11, 55% of headcount.

Anthology Filings

Explore SEC and related filing metadata, where available.

Anthology filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Anthology's valuation, stock price, and market status.

Is Anthology a public or private company?

Anthology is a private company.

What is the current stock price of Anthology?

Anthology is a private company with no public stock price. No recent secondary market data is available.

How much is Anthology worth (valuation)?

Valuation information for Anthology is not publicly available.

Can I buy Anthology stock?

Anthology shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Anthology's last funding round?

Anthology's most recent funding round was Grant on December 20, 2024.

Who are the main investors in Anthology?

Key investors in Anthology include Dolby Family Ventures, Engine Ventures, Climate Capital, BoxOne Ventures, Defense Advanced Research Projects Agency.

Will Anthology IPO soon?

No public IPO plans have been announced for Anthology.

How can I track Anthology secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Anthology's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersCambridge, Massachusetts
Employee Range11
Year Founded2023
Last FundingMar 20, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?